Loading...
Header Logo
Keywords
Last Name
Institution

Thomas Greenough

Concepts (175)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Herpesvirus 4, Human
4
2015
132
1.330
Why?
Infectious Mononucleosis
3
2015
25
1.310
Why?
SARS Virus
7
2006
19
1.120
Why?
HIV-1
10
2012
580
1.050
Why?
CD8-Positive T-Lymphocytes
4
2015
507
1.000
Why?
Severe Acute Respiratory Syndrome
5
2006
16
0.830
Why?
HIV Infections
6
2011
632
0.650
Why?
Antibodies, Viral
4
2012
212
0.590
Why?
AIDS Vaccines
2
2011
54
0.550
Why?
Antiretroviral Therapy, Highly Active
3
2011
90
0.490
Why?
Apoptosis Regulatory Proteins
1
2010
113
0.480
Why?
Antigens, CD
1
2010
290
0.450
Why?
Viral Envelope Proteins
4
2005
82
0.450
Why?
Fowlpox virus
1
2008
2
0.450
Why?
Receptors, Antigen, T-Cell
1
2010
237
0.440
Why?
Antibodies, Monoclonal
3
2006
685
0.410
Why?
Callithrix
1
2005
9
0.360
Why?
Monkey Diseases
1
2005
5
0.360
Why?
Membrane Glycoproteins
4
2005
623
0.350
Why?
Immunization, Passive
1
2005
85
0.330
Why?
Pneumonia
1
2005
134
0.320
Why?
Simian immunodeficiency virus
3
2012
40
0.300
Why?
Cell Nucleus
1
2005
503
0.270
Why?
Neutralization Tests
4
2012
123
0.270
Why?
Virus Replication
6
2011
263
0.220
Why?
RNA, Viral
3
2011
193
0.210
Why?
B-Lymphocytes
2
2014
537
0.210
Why?
Adolescent
5
2015
3939
0.200
Why?
Humans
20
2016
33683
0.190
Why?
Uveitis
1
2016
13
0.180
Why?
Cell Line
8
2012
1755
0.180
Why?
Ebolavirus
1
2016
15
0.180
Why?
Hemorrhagic Fever, Ebola
1
2016
14
0.180
Why?
Receptors, Interleukin-7
1
2015
18
0.180
Why?
Acute Disease
2
2015
527
0.180
Why?
Antigens, CD38
1
2015
18
0.180
Why?
Viral Matrix Proteins
2
2014
49
0.180
Why?
Cells, Cultured
3
2010
1821
0.170
Why?
Oropharynx
1
2014
9
0.160
Why?
Lung
3
2006
447
0.160
Why?
Epstein-Barr Virus Infections
1
2014
52
0.150
Why?
CD4-Positive T-Lymphocytes
3
2012
530
0.150
Why?
Vaccines, Synthetic
2
2011
52
0.140
Why?
Sequence Analysis, DNA
3
2014
294
0.140
Why?
Genetic Variation
1
2014
235
0.140
Why?
Up-Regulation
2
2010
322
0.130
Why?
Molecular Sequence Data
5
2014
2081
0.130
Why?
Viremia
1
2011
34
0.130
Why?
nef Gene Products, Human Immunodeficiency Virus
2
2008
13
0.130
Why?
DNA, Complementary
1
2011
183
0.120
Why?
Peptidyl-Dipeptidase A
3
2004
10
0.120
Why?
Dengue
1
2011
116
0.120
Why?
Female
5
2015
18527
0.120
Why?
Poxviridae
1
2009
6
0.120
Why?
Anti-Retroviral Agents
1
2009
42
0.110
Why?
Young Adult
3
2014
2074
0.110
Why?
CD4-CD8 Ratio
1
2008
12
0.110
Why?
CD4 Lymphocyte Count
1
2008
83
0.110
Why?
Ferritins
1
2008
27
0.110
Why?
Gene Products, gag
1
2008
57
0.110
Why?
Epitope Mapping
2
2005
35
0.110
Why?
Vaccinia
1
2008
42
0.110
Why?
Animals
9
2012
14891
0.110
Why?
Male
4
2016
17020
0.110
Why?
Virulence Factors
1
2008
55
0.110
Why?
Protein Binding
3
2012
1224
0.100
Why?
Adult
5
2015
9532
0.100
Why?
Carboxypeptidases
2
2004
8
0.100
Why?
Gene Expression
1
2010
613
0.100
Why?
Antigens, CD4
1
2008
123
0.100
Why?
Interferon-alpha
1
2008
99
0.100
Why?
Transcription Factors
1
2015
1212
0.100
Why?
Mutation
2
2005
1743
0.100
Why?
HIV Antibodies
1
2008
116
0.100
Why?
Amino Acid Sequence
3
2005
1521
0.100
Why?
Interferon-gamma
1
2008
497
0.090
Why?
Flow Cytometry
1
2008
616
0.090
Why?
Viral Structural Proteins
1
2005
17
0.090
Why?
Mice, Transgenic
2
2008
960
0.090
Why?
HIV Long-Term Survivors
1
2005
10
0.090
Why?
Gene Products, vif
1
2005
7
0.090
Why?
vif Gene Products, Human Immunodeficiency Virus
1
2005
10
0.090
Why?
Dendritic Cells
1
2008
385
0.090
Why?
Antibody Specificity
1
2005
99
0.090
Why?
Tissue Distribution
1
2005
229
0.080
Why?
Amino Acid Motifs
1
2005
122
0.080
Why?
Cytokines
1
2008
716
0.080
Why?
Lymph Nodes
1
2005
183
0.080
Why?
Leukemia Virus, Murine
1
2004
29
0.080
Why?
Hepatocytes
1
2005
112
0.080
Why?
Endopeptidases
1
2004
63
0.080
Why?
HIV Long Terminal Repeat
1
2003
17
0.080
Why?
Prospective Studies
1
2008
1612
0.080
Why?
Viral Load
3
2011
157
0.080
Why?
Genes, nef
1
2003
6
0.080
Why?
Myocardium
1
2005
196
0.080
Why?
Epitopes
1
2005
250
0.080
Why?
Antigens, Differentiation, B-Lymphocyte
1
2003
24
0.080
Why?
T-Lymphocytes
1
2008
898
0.080
Why?
Heart
1
2005
208
0.080
Why?
HIV
1
2003
56
0.080
Why?
Disease Models, Animal
2
2006
1202
0.070
Why?
Mice, Inbred BALB C
1
2005
811
0.070
Why?
Histocompatibility Antigens Class II
1
2003
154
0.070
Why?
Phylogeny
2
2014
242
0.070
Why?
Inflammation
1
2005
659
0.060
Why?
Promoter Regions, Genetic
1
2003
584
0.060
Why?
Child
4
2011
2608
0.060
Why?
Monocytes
1
2002
304
0.060
Why?
Mice
3
2008
7520
0.060
Why?
Immunoglobulin G
2
2012
335
0.050
Why?
Liberia
1
2016
8
0.050
Why?
Tomography, Optical Coherence
1
2016
83
0.040
Why?
Vero Cells
2
2005
51
0.040
Why?
Time Factors
2
2014
2592
0.040
Why?
Cercopithecus aethiops
2
2005
176
0.040
Why?
Transfection
2
2008
640
0.040
Why?
Child, Preschool
2
2011
1295
0.040
Why?
Jurkat Cells
2
2003
72
0.040
Why?
Receptors, Virus
2
2004
96
0.040
Why?
Cluster Analysis
1
2014
198
0.040
Why?
DNA, Viral
1
2014
176
0.040
Why?
Macaca
1
2012
17
0.040
Why?
Virology
1
2012
11
0.040
Why?
Antibody-Dependent Cell Cytotoxicity
1
2012
19
0.040
Why?
Receptors, IgG
1
2012
25
0.040
Why?
HIV Envelope Protein gp120
1
2012
116
0.030
Why?
Killer Cells, Natural
1
2012
188
0.030
Why?
Cross Reactions
1
2011
141
0.030
Why?
Enzyme-Linked Immunosorbent Assay
1
2012
405
0.030
Why?
Vaccination
1
2011
123
0.030
Why?
Treatment Failure
1
2011
117
0.030
Why?
Genome, Viral
1
2011
60
0.030
Why?
Pyrimidines
1
2011
69
0.030
Why?
Piperazines
1
2011
96
0.030
Why?
Drug Resistance, Viral
1
2011
97
0.030
Why?
Reproducibility of Results
1
2012
986
0.030
Why?
Infant, Newborn
1
2011
714
0.030
Why?
Immunization
1
2009
115
0.030
Why?
Hypergammaglobulinemia
1
2008
4
0.030
Why?
Infant
1
2011
944
0.030
Why?
Statistics as Topic
1
2008
140
0.030
Why?
Genotype
1
2009
477
0.030
Why?
Cytotoxicity, Immunologic
1
2007
158
0.020
Why?
Kidney
1
2008
282
0.020
Why?
NF-kappa B
1
2008
391
0.020
Why?
Lung Diseases, Interstitial
1
2006
20
0.020
Why?
Mesocricetus
1
2006
106
0.020
Why?
Nucleocapsid Proteins
1
2005
16
0.020
Why?
Cohort Studies
1
2009
1358
0.020
Why?
Lymphocyte Activation
1
2008
694
0.020
Why?
Immunologic Memory
1
2007
282
0.020
Why?
Immunotherapy
1
2006
85
0.020
Why?
Cricetinae
1
2006
411
0.020
Why?
3T3 Cells
1
2004
98
0.020
Why?
Treatment Outcome
1
2011
2569
0.020
Why?
U937 Cells
1
2003
11
0.020
Why?
Giant Cells
1
2003
14
0.020
Why?
Cell Proliferation
1
2007
658
0.020
Why?
Virion
1
2004
102
0.020
Why?
Gene Products, nef
1
2003
9
0.020
Why?
Molecular Weight
1
2003
200
0.020
Why?
Solubility
1
2003
148
0.020
Why?
Macrophages
1
2008
733
0.020
Why?
Antibodies
1
2003
157
0.020
Why?
Acquired Immunodeficiency Syndrome
1
2003
138
0.020
Why?
Alleles
1
2003
310
0.020
Why?
Leukocytes, Mononuclear
1
2003
214
0.020
Why?
Middle Aged
2
2008
9750
0.020
Why?
Down-Regulation
1
2003
256
0.020
Why?
Coculture Techniques
1
2002
79
0.020
Why?
Disease Progression
1
2003
472
0.020
Why?
Protein Structure, Tertiary
1
2003
689
0.020
Why?
Base Sequence
1
2003
1259
0.020
Why?
Rats
1
2004
1783
0.020
Why?
Greenough's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_